DE69533197D1 - Liposomale mitteln - Google Patents

Liposomale mitteln

Info

Publication number
DE69533197D1
DE69533197D1 DE69533197T DE69533197T DE69533197D1 DE 69533197 D1 DE69533197 D1 DE 69533197D1 DE 69533197 T DE69533197 T DE 69533197T DE 69533197 T DE69533197 T DE 69533197T DE 69533197 D1 DE69533197 D1 DE 69533197D1
Authority
DE
Germany
Prior art keywords
liposomal
liposomal means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69533197T
Other languages
English (en)
Other versions
DE69533197T2 (de
Inventor
Martha Garrity
John Varadarajan
David Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health Salutar Inc
Original Assignee
Amersham Health Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health Salutar Inc filed Critical Amersham Health Salutar Inc
Application granted granted Critical
Publication of DE69533197D1 publication Critical patent/DE69533197D1/de
Publication of DE69533197T2 publication Critical patent/DE69533197T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69533197T 1994-10-10 1995-10-09 Liposomale Mittel Expired - Lifetime DE69533197T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420390A GB9420390D0 (en) 1994-10-10 1994-10-10 Liposomal agents
GB9420390 1994-10-10
PCT/GB1995/002378 WO1996011023A1 (en) 1994-10-10 1995-10-09 Liposomal agents

Publications (2)

Publication Number Publication Date
DE69533197D1 true DE69533197D1 (de) 2004-07-29
DE69533197T2 DE69533197T2 (de) 2005-07-28

Family

ID=10762605

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69533197T Expired - Lifetime DE69533197T2 (de) 1994-10-10 1995-10-09 Liposomale Mittel

Country Status (10)

Country Link
US (1) US6045821A (de)
EP (1) EP0785804B1 (de)
JP (1) JP4057646B2 (de)
CN (1) CN1168636A (de)
AU (1) AU3613695A (de)
CA (1) CA2200867A1 (de)
DE (1) DE69533197T2 (de)
GB (1) GB9420390D0 (de)
MX (1) MX9702523A (de)
WO (1) WO1996011023A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19726282A1 (de) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
TR200102778T2 (tr) * 1999-03-11 2002-05-21 Fujisawa Pharmaceutical Co. Ltd. Lipozom preparatları
US6479300B1 (en) * 1999-03-15 2002-11-12 Millipore Corporation Metal loaded ligand bound membranes for metal ion affinity chromatography
US6379698B1 (en) 1999-04-06 2002-04-30 Isis Pharmaceuticals, Inc. Fusogenic lipids and vesicles
US6864219B2 (en) 2000-01-17 2005-03-08 Bayer Aktiengesellschaft Substituted aryl ketones
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
KR100866666B1 (ko) 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US20040077604A1 (en) * 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
WO2002077037A2 (en) * 2001-03-22 2002-10-03 The Administrators Of The Tulane Educational Fund Biaryl monomers and dendritic polymers derived therefrom
DK1379674T3 (da) * 2001-04-17 2012-03-12 Danisco Us Inc Fremgangsmåde til at binde enzym til bærestof ved anvendelse af kationiske copolymerer og produkter fremstillet derved
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
RU2303042C2 (ru) 2001-07-10 2007-07-20 Джи-И Хелткер АС Соединения на основе пептидов для направленной доставки к рецепторам интегринов
EP1420831A1 (de) * 2001-07-27 2004-05-26 Targesome, Inc. Lipid-konstrukte als therapeutische und bildgebende mittel
US7087212B2 (en) * 2001-08-17 2006-08-08 Mallinckrodt, Inc Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
EP1432403B1 (de) 2001-10-03 2010-07-28 Celator Pharmaceuticals, Inc. Liposomenladung mit metallionen
US7381426B2 (en) * 2002-01-24 2008-06-03 Southwest Research Institute Targeted delivery of bioactive factors to the systemic skeleton
US7432371B2 (en) * 2002-02-07 2008-10-07 Covalent Partners, Llc Nanofilm and membrane compositions
WO2003066646A2 (en) * 2002-02-07 2003-08-14 Covalent Partners, Llc Macrocyclic module compositions
US20040034223A1 (en) * 2002-02-07 2004-02-19 Covalent Partners, Llc. Amphiphilic molecular modules and constructs based thereon
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
US7184663B2 (en) * 2002-05-29 2007-02-27 Fujitsu Limited Optical ring network with hub node and method
CN1245153C (zh) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 一种维生素a脂质体及其制备方法
US20040106741A1 (en) * 2002-09-17 2004-06-03 Kriesel Joshua W. Nanofilm compositions with polymeric components
EP1466629A1 (de) * 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Adducte zwischen NMR Vershibungsreagenzen und Substraten mit austauschbaren Protonen für die "CEST" Anwendung
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
EP1667965A2 (de) * 2003-08-06 2006-06-14 Covalent Partners, LLC Zusammensetzungen verbrückter makrocyclischer module
US20070189973A1 (en) * 2003-11-21 2007-08-16 Junji Nishigaki Contrast medium comprising liposomes containing hydrophobic chelate compound
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
ATE493152T1 (de) * 2004-09-23 2011-01-15 Guerbet Sa Liposomale kontrastmittel für die cest-bildgebung
FR2875410B1 (fr) * 2004-09-23 2012-11-16 Guerbet Sa Composes de diagnostique pour le ciblage de recpteur a chimiokines
JP5082446B2 (ja) * 2004-11-10 2012-11-28 コニカミノルタエムジー株式会社 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム
DE102005018330B4 (de) 2005-04-20 2007-04-19 Siemens Ag System zur Erzeugung von CT-Bilddatensätzen und zur Bestrahlung eines Tumor-Patienten
NO20052428D0 (no) * 2005-05-20 2005-05-20 Amersham Health As Kontrastmidler
WO2007088051A2 (en) 2006-01-31 2007-08-09 Bayer Schering Pharma Aktiengesellschaft Modulation of mdl-1 activity for treatment of inflammatory disease
NO329127B1 (no) 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
CN1962683A (zh) * 2006-12-18 2007-05-16 张文芳 聚乙二醇修饰的甾醇共聚物及其应用
FR2914304B1 (fr) 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
FR2914303A1 (fr) 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
WO2008134289A2 (en) * 2007-04-26 2008-11-06 Mallinckrodt Inc. High relaxivity coordinatively unsaturated lanthanide complexes
WO2009039192A2 (en) 2007-09-17 2009-03-26 The Regents Of The University Of Californina Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
DE102008003615A1 (de) * 2008-01-09 2009-07-16 Magforce Nanotechnologies Ag Magnetische Transducer
KR101094207B1 (ko) * 2008-08-21 2011-12-14 연세대학교 산학협력단 Ｔ１―ｔ２ 이중방식 ｍｒｉ 조영제
JP5657902B2 (ja) * 2010-03-17 2015-01-21 株式会社コスモステクニカルセンター ポリオキシアルキレンステロールエーテル誘導体及び／又はポリオキシアルキレンスタノールエーテル誘導体、及びそれを含有する外用剤組成物
EP2575896A2 (de) * 2010-05-26 2013-04-10 Erik Reimhult Magnetisch reaktive membranstrukturen
CN105388287A (zh) 2011-03-11 2016-03-09 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
EP3038115B1 (de) 2011-08-10 2020-05-06 MagForce AG Herstellungsverfahren von agglomeration magnetischer alkoxysilanbeschichteter nanopartikel
KR102162901B1 (ko) 2011-09-29 2020-10-08 피엘엑스 옵코 인코포레이티드 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
CN104703594B (zh) * 2012-08-10 2018-01-23 大鹏药品工业株式会社 稳定的封装奥沙利铂的脂质体的水分散体及其稳定化方法
CN104755108B (zh) * 2012-10-25 2018-04-27 艾姆戈特株式会社 结合含有药物的纳米粒子的超声波造影剂及其制造方法
EP2918262B1 (de) 2014-03-10 2023-08-09 PLS-Design GmbH Induktion einer antigenspezifischen Toleranz durch periphere Phagozytose
EP3142656B1 (de) * 2015-01-21 2018-10-17 Pacira Pharmaceuticals, Inc. Multivesikuläre liposomformulierungen von tranexamsäure
EP3370779A1 (de) * 2015-11-06 2018-09-12 Wisconsin Alumni Research Foundation Auf gadolinium basierende tumorgezielte langlebige kontrastmittel und therapeutika
JP6983779B2 (ja) 2015-11-30 2021-12-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 非常に特異的な腫瘍細胞表面抗原を標的とするヒト抗体を用いた腫瘍特異的ペイロード送達及び免疫活性化
CN105693807B (zh) * 2016-01-25 2018-06-12 四川大学 新型脑靶向脂质材料及其在药物传递系统中的应用
JP7438756B2 (ja) * 2016-07-25 2024-02-27 ウイスコンシン アラムナイ リサーチ ファウンデーシヨン Ｉｎ ｓｉｔｕ免疫調節癌ワクチン接種のための標的化された放射線治療用キレート
IL264363B2 (en) * 2016-07-25 2024-05-01 Wisconsin Alumni Res Found Radioactive metal phospholipid chelates for cancer imaging and therapy
CN115666523A (zh) 2020-03-26 2023-01-31 Plx 奥普科有限公司 能够进行pH依赖性重构的药物载体及其制备和使用方法
WO2022032020A1 (en) 2020-08-07 2022-02-10 Fortis Therapeutics, Inc. Immunoconjugates targeting cd46 and methods of use thereof
CN112180079B (zh) * 2020-09-25 2024-04-19 上海睿康生物科技有限公司 一种稳定的脂质体颗粒及其在免疫比浊检测中的应用
US11980636B2 (en) 2020-11-18 2024-05-14 Jazz Pharmaceuticals Ireland Limited Treatment of hematological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603044A (en) * 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
GB8824593D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5053503A (en) * 1989-02-17 1991-10-01 Centocor Chelating agents
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
EP0594640A4 (en) * 1991-05-23 1998-06-03 Evan C Unger Liposoluble compounds for magnetic resonance imaging
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US5472605A (en) * 1994-03-10 1995-12-05 Hemasure, Inc. Filtration device useable for removal of leukocytes and other blood components
GB9407435D0 (en) * 1994-04-14 1994-06-08 Nycomed Salutar Inc Compounds

Also Published As

Publication number Publication date
AU3613695A (en) 1996-05-02
EP0785804A1 (de) 1997-07-30
CA2200867A1 (en) 1996-04-18
MX9702523A (es) 1997-06-28
DE69533197T2 (de) 2005-07-28
EP0785804B1 (de) 2004-06-23
WO1996011023A1 (en) 1996-04-18
JP4057646B2 (ja) 2008-03-05
GB9420390D0 (en) 1994-11-23
JPH10507172A (ja) 1998-07-14
US6045821A (en) 2000-04-04
CN1168636A (zh) 1997-12-24

Similar Documents

Publication Publication Date Title
DE69533197D1 (de) Liposomale mitteln
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
DE59501347D1 (de) Hydroxyphenylharnstoffe
ATA108995A (de) Differenzdruckakkumulator
DE59503633D1 (de) Zyklonsichter
BR9506519A (pt) Azatrioxaspiroalquenos
FI940632A0 (fi) Kombinerat braensle- och ellaos
FI944403A0 (fi) Stigkaelke II
FI1360U1 (fi) Justerbar inpassningsdetalj
ATE197372T1 (de) Vorteig
FI1464U1 (fi) Dykarhandske
BR9400287A (pt) Bi-vaso sanitário
BR7401967U (pt) Vassoura-mangueira
BR9403098A (pt) Turnimetro
BR9402584A (pt) Chavecheque
BR9401966A (pt) Intervalômetro-foto ARJ-07
BR9401864A (pt) Pescoço-giratório
BR9401264A (pt) Prevgás
BR9401008A (pt) Helistato
BR9400290A (pt) Selo-contrato
BR9403310A (pt) Regulex
BR9403758A (pt) Multiplic
NO944050D0 (no) Sparkebil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 785804

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB